PE117199A1 - PARASITICIDE FORMULATIONS - Google Patents
PARASITICIDE FORMULATIONSInfo
- Publication number
- PE117199A1 PE117199A1 PE1998000903A PE00090398A PE117199A1 PE 117199 A1 PE117199 A1 PE 117199A1 PE 1998000903 A PE1998000903 A PE 1998000903A PE 00090398 A PE00090398 A PE 00090398A PE 117199 A1 PE117199 A1 PE 117199A1
- Authority
- PE
- Peru
- Prior art keywords
- implant
- parasiticide
- parasiticide formulations
- formulations
- milbemycin
- Prior art date
Links
- 230000000590 parasiticidal effect Effects 0.000 title abstract 2
- 239000002297 parasiticide Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000007943 implant Substances 0.000 abstract 2
- 239000005660 Abamectin Substances 0.000 abstract 1
- 241000283690 Bos taurus Species 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241001494479 Pecora Species 0.000 abstract 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 210000005069 ears Anatomy 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UN IMPLANTE SOLIDO QUE COMPRENDE: A) AL MENOS UN COMPUESTO PARASITICIDA QUE TIENE UNA BAJA SOLUBILIDAD ACUOSA POR DEBAJO DE 100 �g/ml, Y QUE PUEDE SER AVERMECTINA, MILBEMICINA, ENTRE OTROS; Y B) EXCIPIENTES DE COMPRESION, ENTRE LOS QUE SE INCLUYE UN AGENTE DE RELLENO TAL COMO LACTOSA. EL PRESENTE IMPLANTE TIENE FORMA DE BARRITA Y ESTA ADAPTADO PARA LA IMPLANTACION EN LAS OREJAS DE VACAS U OVEJAS O CUALQUIER ANIMAL QUE LO REQUIERA, DE MANERA QUE LES PROPORCIONE PROTECCION PROLONGADA FRENTE A PARASITOSIT REFERS TO A SOLID IMPLANT THAT INCLUDES: A) AT LEAST ONE PARASITICIDE COMPOUND THAT HAS A LOW AQUEOUS SOLUBILITY BELOW 100 �g / ml, AND WHICH MAY BE AVERMECTIN, MILBEMYCIN, AMONG OTHERS; AND B) COMPRESSION EXCIPIENTS, INCLUDING A FILLING AGENT SUCH AS LACTOSE. THIS IMPLANT IS IN THE SHAPE OF A BAR AND IS ADAPTED FOR IMPLEMENTATION IN THE EARS OF COWS OR SHEEP OR ANY ANIMAL THAT REQUIRES IT, SO THAT IT PROVIDES THEM PROLONGED PROTECTION AGAINST PARASITES
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9720228.7A GB9720228D0 (en) | 1997-09-23 | 1997-09-23 | Parasiticidal formulations |
| GBGB9810143.9A GB9810143D0 (en) | 1998-05-12 | 1998-05-12 | Parasiticidal formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE117199A1 true PE117199A1 (en) | 1999-11-20 |
Family
ID=26312302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000903A PE117199A1 (en) | 1997-09-23 | 1998-09-22 | PARASITICIDE FORMULATIONS |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1014970A1 (en) |
| JP (1) | JP2001517622A (en) |
| AP (1) | AP9801350A0 (en) |
| AR (1) | AR013509A1 (en) |
| AU (1) | AU9742298A (en) |
| BR (1) | BR9812385A (en) |
| CA (1) | CA2304283A1 (en) |
| GT (1) | GT199800149A (en) |
| MA (1) | MA24655A1 (en) |
| PA (1) | PA8459501A1 (en) |
| PE (1) | PE117199A1 (en) |
| TN (1) | TNSN98175A1 (en) |
| WO (1) | WO1999015166A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP279698A0 (en) * | 1998-04-03 | 1998-04-30 | Sunscape Developments Limited | Sustained release formulation |
| US6645192B2 (en) | 1998-09-30 | 2003-11-11 | Ivy Animal Health, Inc. | Pellet implant system for immediate and delayed release of antiparasitic drug |
| AU1556000A (en) * | 1999-11-22 | 2001-06-04 | Akzo Nobel N.V. | Composition allowing predefined and controlled release of active ingredient, preparation thereof and use |
| US6953586B1 (en) | 2000-06-08 | 2005-10-11 | Ivy Animal Health, Inc. | Growth promoting pharmaceutical implant |
| DE10032878A1 (en) * | 2000-07-06 | 2002-01-17 | Bayer Ag | Anthelmintics to prevent parasitic infections in humans and animals |
| AUPR602501A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
| AUPR602401A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release delivery system |
| AUPR610501A0 (en) * | 2001-07-04 | 2001-07-26 | Smart Drug Systems Inc | Treatment of parasitic disease |
| US7918863B2 (en) | 2005-06-24 | 2011-04-05 | Conceptus, Inc. | Minimally invasive surgical stabilization devices and methods |
| EP3634583A4 (en) * | 2017-06-06 | 2021-03-03 | Merck Sharp & Dohme Corp. | LONG-ACTION IMPLANT FOR THE TREATMENT OF INFECTIOUS DISEASES |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0240274A3 (en) * | 1986-04-03 | 1990-03-14 | Merck & Co. Inc. | Avermectins as growth promotant agents |
| US4847243A (en) * | 1987-10-08 | 1989-07-11 | Merck & Co., Inc. | Treatment for fescue toxicosis in grazing animals |
| NZ239370A (en) * | 1990-08-22 | 1994-04-27 | Merck & Co Inc | Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone |
| US5411737A (en) * | 1991-10-15 | 1995-05-02 | Merck & Co., Inc. | Slow release syneresing polymeric drug delivery device |
-
1998
- 1998-09-04 CA CA002304283A patent/CA2304283A1/en not_active Abandoned
- 1998-09-04 JP JP2000512535A patent/JP2001517622A/en active Pending
- 1998-09-04 AU AU97422/98A patent/AU9742298A/en not_active Abandoned
- 1998-09-04 EP EP98951367A patent/EP1014970A1/en not_active Withdrawn
- 1998-09-04 WO PCT/EP1998/005720 patent/WO1999015166A1/en not_active Ceased
- 1998-09-04 BR BR9812385-8A patent/BR9812385A/en not_active IP Right Cessation
- 1998-09-17 AP APAP/P/1998/001350A patent/AP9801350A0/en unknown
- 1998-09-17 PA PA19988459501A patent/PA8459501A1/en unknown
- 1998-09-21 AR ARP980104712A patent/AR013509A1/en unknown
- 1998-09-22 MA MA25268A patent/MA24655A1/en unknown
- 1998-09-22 GT GT199800149A patent/GT199800149A/en unknown
- 1998-09-22 TN TNTNSN98175A patent/TNSN98175A1/en unknown
- 1998-09-22 PE PE1998000903A patent/PE117199A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2304283A1 (en) | 1999-04-01 |
| PA8459501A1 (en) | 2000-05-24 |
| AU9742298A (en) | 1999-04-12 |
| WO1999015166A1 (en) | 1999-04-01 |
| TNSN98175A1 (en) | 2005-03-15 |
| GT199800149A (en) | 2000-03-15 |
| BR9812385A (en) | 2000-09-12 |
| AR013509A1 (en) | 2000-12-27 |
| EP1014970A1 (en) | 2000-07-05 |
| AP9801350A0 (en) | 2000-03-17 |
| JP2001517622A (en) | 2001-10-09 |
| MA24655A1 (en) | 1999-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20000939A1 (en) | FSH FORMULATIONS AND FSH VARIANTS, PRODUCTS AND METHODS | |
| ES2077530B1 (en) | PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS TO CURE TUMOR DISEASES. | |
| AR044433A1 (en) | REPELLENT COMPOSITION AGAINST INSECTS, METHOD FOR REDUCING THE INCIDENCE OF AN INFECTIOUS DISEASE CAUSED BY AN OBJECTIVE PEST THAT INCLUDES SUCH COMPOSITION AND ITS USES | |
| BR0114799A (en) | Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents | |
| ES2067696T3 (en) | SUSTAINED RELEASE COMPOSITIONS TO TREAT PERIODONTAL DISEASE. | |
| AR013488A1 (en) | AQUEOUS GERMICIDAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF INFECTIOUS DISEASES OF ANIMAL FISH, AND USE OF SUCH COMPOSITION | |
| BR0008405A (en) | Factor viii composition formulated without the addition of albumin, use of a factor viii composition, and method of lyophilizing an aqueous pharmaceutical formulation | |
| ES2139021T3 (en) | DETERGENT-IODINE GERMICIDAL COMPOSITIONS WHICH HAVE A REDUCED DETERGENT CONTENT. | |
| BRPI0412975A (en) | penetrating foam for pharmaceutical use | |
| PA8484301A1 (en) | PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION | |
| CR7089A (en) | LIQUID FORMULATIONS FOR DERMIC APPLICATION FOR THE FIGHT AGAINST PARASITING INSECTS IN ANIMALS | |
| ES2195169T3 (en) | VACCINES AGAINST CALMIDIES AND IMMUNOGENIC COMPOSITIONS CONTAINING AN EXTERNAL MEMBRANE ANTIGEN AND METHODS FOR PREPARATION. | |
| ES2146300T3 (en) | USE OF ANTIHELMINTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS CAUSED BY ANOPLOCEPHALA PERFOLIATA IN EQUIDS. | |
| PE117199A1 (en) | PARASITICIDE FORMULATIONS | |
| ES2162319T3 (en) | USE OF THE CLIOQUINOL CHELATING AGENT FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE. | |
| ES2063033T3 (en) | USE OF IGF-II IN THE TREATMENT OF BONE DISEASES. | |
| ES2094702B1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF CANCER DISEASES AND PROCEDURE FOR THEIR PREPARATION. | |
| AR017925A1 (en) | A WATERY FORMULATION TO VERTER, TOPICALLY ACCEPTABLE, ADAPTED FOR ITS EXTERNAL APPLICATION LOCATED IN AN ANIMAL, ITS USE AND A METHOD TO FORMULATE IT | |
| PE3096A1 (en) | FORMULATION CONTAINING SELENIUM | |
| AR021690A1 (en) | USE OF KTQ1 CHANNEL INHIBITORS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES, WHICH ARE CAUSED BY YECTOPARASITES HELMENTS. | |
| ES2036589T5 (en) | A PROCEDURE FOR THE PREPARATION OF A VETERINARY COMPOSITION FOR USE IN THE TREATMENT OR PROPHYLAXIS OF BREAST ALTERATIONS IN NON-HUMAN ANIMALS. | |
| ES2163631T3 (en) | AN IMPROVED PEPTIDE, IMMUNOGENIC COMPOSITION AND VACCINE OR MEDICAL PREPARATION, A PROCEDURE TO IMMUNIZE ANIMALS AGAINST LHRH HORMONE, ANALOGS OF LHRH PEPTIDE REPEATED IN TANDEM AND ITS USE AS A VACCINE. | |
| PA8459201A1 (en) | ANTIMASTIC PHARMACEUTICAL COMPOSITION BASED ON EXTRACTS OF NATURAL ORIGIN AND PROCEDURE TO MANUFACTURE IT | |
| ES2185310T3 (en) | HERBAL ANTIVIRICAL AGENT. | |
| MX172107B (en) | PROCEDURE FOR DISINFECTION OF MASSES FOR MEDICINAL EMPTYING |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |